3.47
price up icon1.76%   0.06
after-market Handel nachbörslich: 3.47
loading
Schlusskurs vom Vortag:
$3.41
Offen:
$3.36
24-Stunden-Volumen:
16,818
Relative Volume:
0.21
Marktkapitalisierung:
$8.95M
Einnahmen:
$102.80K
Nettoeinkommen (Verlust:
$-5.32M
KGV:
-0.9132
EPS:
-3.8
Netto-Cashflow:
$-5.45M
1W Leistung:
+1.76%
1M Leistung:
-0.86%
6M Leistung:
+62.15%
1J Leistung:
-22.89%
1-Tages-Spanne:
Value
$3.30
$3.50
1-Wochen-Bereich:
Value
$3.30
$3.6899
52-Wochen-Spanne:
Value
$1.69
$6.90

Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile

Name
Firmenname
Creative Medical Technology Holdings Inc
Name
Telefon
480-399-2822
Name
Adresse
211 E. OSBORN RD., PHOENIX
Name
Mitarbeiter
4
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
CELZ's Discussions on Twitter

Vergleichen Sie CELZ mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CELZ
Creative Medical Technology Holdings Inc
3.47 8.80M 102.80K -5.32M -5.45M -3.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Creative Medical Technology Holdings Inc Aktie (CELZ) Neueste Nachrichten

pulisher
06:59 AM

Live market analysis of Creative Medical Technology Holdings Inc.July 2025 Movers & Daily Stock Trend Reports - newser.com

06:59 AM
pulisher
Oct 13, 2025

Is Creative Medical Technology Holdings Inc. stock affected by interest rate hikesPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is now a turning point for Creative Medical Technology Holdings Inc.2025 Support & Resistance & Low Risk Profit Maximizing Plans - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Why Creative Medical Technology Holdings Inc. is moving todayMarket Risk Analysis & Expert-Curated Trade Recommendations - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How Creative Medical Technology Holdings Inc. stock performs in weak economyJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will LEN.B stock remain on Wall Street radarMarket Activity Summary & Real-Time Stock Price Movement Reports - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What moving averages say about Creative Medical Technology Holdings Inc.Market Growth Summary & Risk Managed Trade Strategies - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is Creative Medical Technology Holdings Inc. reversing from oversold territory2025 Price Action Summary & Expert Curated Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Comparing Creative Medical Technology Holdings Inc. in custom built stock radarsQuarterly Market Review & Momentum Based Trading Signals - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Creative Medical Technology Holdings Inc Stock Analysis and ForecastTechnical Pattern Recognition & Get Tomorrow’s Winners Today With AI - earlytimes.in

Oct 12, 2025
pulisher
Oct 12, 2025

Market reaction to Creative Medical Technology Holdings Inc.’s recent newsEarnings Miss & Fast Gain Stock Trading Tips - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

How currency fluctuations impact Creative Medical Technology Holdings Inc. stockInflation Watch & Technical Pattern Alert System - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Mergers & Acquisitions Tracker - Plastics News

Oct 10, 2025
pulisher
Oct 09, 2025

Mesenchymal Stem Cells/Medicinal Signaling Cells Advances & Applications Report 2025: 1,670+ Trials, 12 Approvals Worldwide, and Path to 50 Approvals by 2040ResearchAndMarkets.com - Business Wire

Oct 09, 2025
pulisher
Oct 09, 2025

Risk adjusted return profile for Creative Medical Technology Holdings Inc. analyzed - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Price action breakdown for Creative Medical Technology Holdings Inc.Weekly Loss Report & Reliable Entry Point Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Type 1 Diabetes Pipeline Drugs Report 2025: Innovative Drug Developments and Ongoing Clinical Studies Uncovered - Barchart.com

Oct 07, 2025
pulisher
Oct 07, 2025

Creative Medical Technology Holdings Congratulates Nobel Laureates and Highlights Recent Patents for ImmCelz™ Platform - Quiver Quantitative

Oct 07, 2025
pulisher
Oct 07, 2025

Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs - MarketScreener

Oct 07, 2025
pulisher
Oct 07, 2025

2 U.S. Patents for ImmCelz: Creative Medical advances supercharged Treg therapy for HF and T1D - Stock Titan

Oct 07, 2025
pulisher
Oct 06, 2025

Is Creative Medical Technology Holdings Inc a good long term investmentEarnings Date Calendar & Start Your Free Trading Journey Today - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

Is Creative Medical Technology Holdings Inc. stock poised for growthWeekly Trade Analysis & Free Expert Approved Momentum Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is ALLT a good long term investmentStock Buyback Announcements & Minimal Capital Trading - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Pattern recognition hints at Creative Medical Technology Holdings Inc. upsideJuly 2025 Recap & Capital Protection Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Short interest data insights for Creative Medical Technology Holdings Inc.Market Weekly Review & Safe Capital Growth Tips - newser.com

Oct 05, 2025
pulisher
Oct 02, 2025

Will New Partnerships Boost TMT (India) Ltd.’s OutlookMarket Liquidity Analysis & High Profit Growth Stocks - earlytimes.in

Oct 02, 2025
pulisher
Sep 30, 2025

Why Hedge Funds Are Buying Gujarat Mineral Development Corporation Limited in YEARCapital Gains Strategies & Free Real-Time Trading Signals - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

The Pipeline for of iPSC-Derived Cell Therapeutics in 2025 - BioInformant

Sep 30, 2025
pulisher
Sep 30, 2025

Is Quadrant Televentures Limited Stock Set to Outperform Its Peers in YEAREquity Performance Review & Machine Learning Stock Picks, Daily - earlytimes.in

Sep 30, 2025

Finanzdaten der Creative Medical Technology Holdings Inc-Aktie (CELZ)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Creative Medical Technology Holdings Inc-Aktie (CELZ) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Finger Michael H.
Director
Feb 18 '25
Sale
5.00
750
3,750
1,101
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):